Therapeutic Testosterone Replacement Therapy (TRT) has blossomed into a multi-billion dollar industry. Millions of American men currently (and in future) will likely find themselves prescribed products like Androderm, AndroGel and other Low T drugs marketed to them as masculinity in a pill.
It is true that short term trials show that Low T drugs can help men with hypogonadism normalize their testosterone levels and enjoy other benefits, such as increased energy, increased libido, increased lean tissue mass and decreased fat mass. However, the evidence of these benefits is far more ambiguous than TRT drug makers would like people to know.
For instance, as Dr. Sergei Romashkan, noted: “The problem is that we don’t have any evidence that prescribing testosterone to older men with relatively low testosterone levels does any good.”
Meanwhile, some evidence suggests that TRT can increase risks for all-cause mortality, including death by heart disease and stroke, and lead to a surprisingly diverse gallery of side effects and symptoms.
Despite the huge popularity of TRT among doctors and patients, the therapy is not conclusively safe for all men; and it may, indeed, predispose some men to develop heart disease, stroke and other very serious complications.
Here are some additional informational resources for testosterone victims and their families:
- Serious Heart Problems and Clots Caused by Testosterone Therapy
- Testosterone Replacement Therapy Side Effects
- Testosterone Supplements Raise Heart Risks in Men
- Testosterone Drugs become $1.6 Billion Market despite Health Risks
If you or someone you love suffered adverse effects while on testosterone therapy, you may be able to bring a legal case to get compensated for your medical bills, lost wages, pain and suffering and other damages. Contact the experienced, effective team here at Davis & Crump today for a free consultation about your next steps at 800-277-0300, or email us at email@example.com. You can also find us on Facebook & Twitter.
We are here to help. Connect with us today.